You are here

cancer

As Trump Cuts Cancer Research Funding, Billionaire Sean Parker Wants To Scale It Up

Forbes

Mon, 03/31/25 - 10:53 am

Parker Institute for Cancer Immunotherapy

FDA rejects Hengrui, Elevar's PD-1 cancer drug combination—again

Fierce Pharma

Sun, 03/23/25 - 11:43 pm

Jiangsu Hengrui

Elevar Therapeutics

Gene therapy loses luster as investors eye quicker returns from weight-loss drugs

Yahoo/Reuters

Fri, 03/21/25 - 11:42 am

drug development

Cell therapy biotech Century Therapeutics axes cancer trial, turns to autoimmune

Fierce Biotech

Thu, 03/20/25 - 11:11 am

Century Therapeutics

autoimmune diseases

Lilly backs precision medicine start-up’s $65 million raise

Chemical and Engineering News

Wed, 03/19/25 - 11:16 am

Ampersand Biosciences

Flagship Pioneering

Nanobiotix tweaks J&J licensing deal for phase 3 cancer drug to eke out cash

Fierce Biotech

Tue, 03/18/25 - 11:17 am

head and neck cancer

AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama

Fierce Pharma

Mon, 03/17/25 - 10:11 pm

subcutaneous drug delivery

Labcorp is buying Bioreference health’s cancer testing business for $192m

MedCity News

Sun, 03/16/25 - 09:52 pm

BioReference Labs

This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year

Motley Fool

Thu, 03/13/25 - 11:32 am

Summit Therapeutics

non-small cell lung cancer

Everest Medicines begins dosing in mRNA cancer vaccine trial

Clinical Trials Arena

Fri, 03/7/25 - 11:02 am

Everest Medicines

cancer vaccines

clinical trials

Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck

MSN/Bloomberg

Wed, 03/5/25 - 11:26 pm

Moderna Therapeutics

clinical trials

Where Will Eli Lilly Be in 5 Years?

Motley Fool

Sun, 03/2/25 - 09:41 pm

ulcerative colitis

NeOnc: bypassing the blood-brain barrier in brain cancer

Clinical Trials Arena

Fri, 02/28/25 - 11:15 am

internasal drug delivery

blood-brain barrier

Perlmutter's Eikon raises $351m in major financing round

Pharmaphorum

Wed, 02/26/25 - 09:58 am

Eikon Therapeutics

Roger Perlmutter

VA and HHS Object to Johnson & Johnson Talc Cancer Plan

Mesothelioma Guide

Sun, 02/16/25 - 07:40 pm

Otsuka breaks up with cancer candidates on strategic grounds

Fierce Biotech

Fri, 02/14/25 - 09:22 am

Amgen ends Ideaya cancer combination trial after partner unveils rival molecule

Fierce Biotech

Thu, 02/13/25 - 09:45 pm

IDEAYA Biosciences

AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment

Pharmaceutical Business Review

Tue, 02/11/25 - 11:27 am

radiopharmaceuticals

alpha radiation

Pfizer taps a former Novartis exec to lead cancer drug push

BioPharma Dive

Thu, 02/6/25 - 11:38 am

Ascentage raises $126m in first biotech IPO of 2025

Pharmaphorum

Mon, 01/27/25 - 11:15 am

Ascentage Pharma

Pages